Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Nuclear Medicine

Free Subscription 13.04.2026 2 Ann Nucl Med 3 Brain 1 Circ Cardiovasc Imaging 34 Clin Nucl Med 1 J Cereb Blood Flow Metab 1 J Nucl Cardiol 5 J Nucl Med 1 JAMA 2 Neurology 8 Nucl Med Commun 1 Phys Med Biol 2 PLoS One 5 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Nucl Med

1. NAKAMOTO Y, Tatsumi M, Nishii R, Kato K, et al
   A narrative review: key evidence from meta-analyses in nuclear medicine.
   Ann Nucl Med. 2026 Apr 7. doi: 10.1007/s12149-026-02201.
   PubMed        
   
   
2. DEMIR B, Hosgoren Alici Y, Araz M, Dursun Avci E, et al
   Impact of shortened dynamic PET/MR protocols on D(1) receptor quantification with [(11)C]?NNC112.
   Ann Nucl Med. 2026 Apr 7. doi: 10.1007/s12149-026-02202.
   PubMed        
   
   

   
   Brain

3. BENINA N, Buitrago L, De Simone FI, Radwan RR, et al
   Plasma pTau 217/beta-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology.
   Brain. 2026;149:1168-1181.
   PubMed         Abstract available
   
   
4. MANASOVA D, Belloli LML, Rosenfelder MJ, Willacker L, et al
   Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness.
   Brain. 2026;149:1381-1395.
   PubMed         Abstract available
   
   
5. KARLSSON L, Janelidze S, Barthelemy NR, Horie K, et al
   Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkers.
   Brain. 2025 Oct 6:awaf375. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

6. BOCZAR KE, deKemp R, Beanlands R
   Myocardial Flow Reserve With (13)N-Ammonia PET: From Quantification to Clinical Consequence.
   Circ Cardiovasc Imaging. 2026 Apr 6:e019571. doi: 10.1161/CIRCIMAGING.126.019571
   PubMed        
   
   

   
   Clin Nucl Med

7. THOSTRUP AH, Bentestuen M, Rasmussen TL, Szejniuk WM, et al
   Thyroiditis Induced by Immune Checkpoint Inhibitors Exhibits High [68Ga]Ga-FAPI-46 and [18F]FDG Uptake on PET/CT: A Case Report.
   Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006444.
   PubMed         Abstract available
   
   
8. BYUN SJ, Choi B
   Unexpected Cortical Uptake on [18F]FP-CIT PET/CT Revealing Delayed Brain Metastases From Renal Cell Carcinoma.
   Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006466.
   PubMed         Abstract available
   
   
9. CHEN M, Franceschi AM
   [18F]-Flortaucipir PET/MRI Supports a 4R Tauopathy Phenotype in Corticobasal Degeneration.
   Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006461.
   PubMed         Abstract available
   
   
10. YAN X, Xie Y, Liu M, Zhu W, et al
    Incidental Detection of a CAIX-avid Breast Invasive Ductal Carcinoma on 68Ga-NY104 PET/CT During Evaluation of a Suspected Renal Mass.
    Clin Nucl Med. 2026 Mar 25. doi: 10.1097/RLU.0000000000006375.
    PubMed         Abstract available
    
    
11. HUANG YE, Huang CK, Huang YT, Tseng JR, et al
    Comparative Detection Performance of PSMA and Non-PSMA PET Tracers in Recurrent and Primary Prostate Cancer: A Systematic Review and Network Meta-Analysis.
    Clin Nucl Med. 2026 Mar 25. doi: 10.1097/RLU.0000000000006349.
    PubMed         Abstract available
    
    
12. MALI MR, Parghane RV, Basu S
    Intramedullary Spinal Cord Metastasis (SCM) From Prostate Carcinoma Detected on [68Ga] Ga-PSMA-11 PET/CT.
    Clin Nucl Med. 2026 Mar 25. doi: 10.1097/RLU.0000000000006326.
    PubMed         Abstract available
    
    
13. DHARMASHAKTU Y, Sanjith, Damle NA, Wakankar R, et al
    68Ga-DOTANOC PET/CT in a Case of Grade 1 Pancreatic NET With Renal Vein and Gonadal Vein Tumor Thrombus.
    Clin Nucl Med. 2026 Mar 25. doi: 10.1097/RLU.0000000000006327.
    PubMed         Abstract available
    
    
14. BUND C, Todeschi J, Lhermitte B, Namer IJ, et al
    Multimodal Approach to a Photopenic Defect on FDOPA PET/MR in a Case of Glioblastoma and its Progression.
    Clin Nucl Med. 2026 Mar 25. doi: 10.1097/RLU.0000000000006434.
    PubMed         Abstract available
    
    
15. ZHENG K, Liu Y, Wang Y, Jing H, et al
    An Asymptomatic Urachal Mucinous Adenocarcinoma on FDG PET/CT.
    Clin Nucl Med. 2026 Mar 25. doi: 10.1097/RLU.0000000000006357.
    PubMed         Abstract available
    
    
16. BARDY R, Detournay E, Guedon AF, Mekinian A, et al
    Prognostic Value of Cranial Arteries Involvement on 18 F-FDG PET/CT at Giant Cell Arteritis Diagnosis in a Multicenter Cohort.
    Clin Nucl Med. 2026 Mar 24. doi: 10.1097/RLU.0000000000006427.
    PubMed         Abstract available
    
    
17. SAHIN OF, Tosunoglu Z, Sahin R, Sahin D, et al
    Diagnostic Performance of 68Ga DOTA-Pentixafor PET/CT in Benign Functional Adrenal Cortical Lesions.
    Clin Nucl Med. 2026 Mar 24. doi: 10.1097/RLU.0000000000006405.
    PubMed         Abstract available
    
    
18. LOPEZ-BERMEJO GARCIA F, Rodriguez Gomez JC, Gaton Ramirez J, Talavera Rubio MDP, et al
    18F-FDG PET/CT Findings in Fahr Syndrome: A Case Report.
    Clin Nucl Med. 2026 Mar 24. doi: 10.1097/RLU.0000000000006414.
    PubMed         Abstract available
    
    
19. WU J, Gao H, He L, Liu N, et al
    Comparison of PSMA/FAPI Bispecific Tracer (1)(8)F-ALF-NOTA-PSFA-1 and (1)(8)F-FDG PET/CT in the Detection of Primary Clear Cell Sarcoma of Bone.
    Clin Nucl Med. 2026 Mar 24. doi: 10.1097/RLU.0000000000006421.
    PubMed         Abstract available
    
    
20. XIANG J, Wang Y, Zhang X, Peng X, et al
    Dual-targeted 68Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer: An Exploratory Comparative Study With 18F-FDG.
    Clin Nucl Med. 2026 Mar 24. doi: 10.1097/RLU.0000000000006422.
    PubMed         Abstract available
    
    
21. DU B, Liu G, Liu Y, Li Y, et al
    Severe Post-treatment Calcification for Prostate Cancer With Dual (1)(8)F-FDG and (6)(8)Ga-PSMA Avidity on PET/CT.
    Clin Nucl Med. 2026 Mar 23. doi: 10.1097/RLU.0000000000006416.
    PubMed         Abstract available
    
    
22. CRUZ ME, Santos MV, Thome U, Sakamoto AC, et al
    Posterior Cortex Deafferentation Following Surgical Disconnection Revealed by 18F-FDG PET/MRI Fusion.
    Clin Nucl Med. 2026 Mar 23. doi: 10.1097/RLU.0000000000006283.
    PubMed         Abstract available
    
    
23. KUMAR SA, Goyal H
    Somatostatin Receptor PET/CT in a Glucagonoma Presenting With Necrolytic Migratory Erythema and Normoglucagonemia: A Diagnostic Dilemma.
    Clin Nucl Med. 2025 Dec 8. doi: 10.1097/RLU.0000000000006259.
    PubMed         Abstract available
    
    
24. TSUKAMOTO S, Koyasu S, Sugimoto A, Sumitomo R, et al
    Intercostal Nodular Fasciitis Mimicking Recurrence of Malignant Lymphoma on FDG-PET/CT.
    Clin Nucl Med. 2026 Apr 7. doi: 10.1097/RLU.0000000000006478.
    PubMed         Abstract available
    
    
25. SAHIN OF, Sahin D, Tosunoglu Z
    The Sunburst Sign in the Mesentery: Unveiling the Diagnosis With (6)(8)Ga DOTATATE PET/CT.
    Clin Nucl Med. 2026 Apr 3. doi: 10.1097/RLU.0000000000006473.
    PubMed         Abstract available
    
    
26. JI X, Dong A
    FDG PET/CT in a Case of Isolated Drain Site Metastasis After Laparotomy Surgery for Rectal Cancer.
    Clin Nucl Med. 2026 Apr 7. doi: 10.1097/RLU.0000000000006479.
    PubMed         Abstract available
    
    
27. SHEN R, Shen L, Xing Y
    Primary High-grade Urothelial Carcinoma of the Prostate With Negative 18F-PSMA PET/CT Imaging.
    Clin Nucl Med. 2026 Apr 9. doi: 10.1097/RLU.0000000000006468.
    PubMed         Abstract available
    
    
28. KAKU T, Nakamoto R, Sakamoto A, Haga H, et al
    A Case of Secondary Chondrosarcoma Arising in Osteochondroma Diagnosed With 18F-FDG PET/CT.
    Clin Nucl Med. 2026 Apr 2. doi: 10.1097/RLU.0000000000006456.
    PubMed         Abstract available
    
    
29. KUMAR SA, Pandit N, Srinivasan P, Goyal H, et al
    False-positive (1)(3)(1)I Uptake in a Carotid Body Tumor Mimicking Nodal Metastasis in Differentiated Thyroid Carcinoma: Implications of Hybrid SPECT/CT.
    Clin Nucl Med. 2026 Apr 2. doi: 10.1097/RLU.0000000000006436.
    PubMed         Abstract available
    
    
30. KOMORI S, Narita Y, Kato T, Momose T, et al
    Potential Role of 18F-FAPI-74 PET/CT in Proton Beam Therapy for Liver Metastasis: Clinical Insights and Limitations.
    Clin Nucl Med. 2026 Apr 2. doi: 10.1097/RLU.0000000000006448.
    PubMed         Abstract available
    
    
31. SABUNCU S, Karyagar S, Seyhan EC, Unver N, et al
    A Case of Incidental Adenoid Cystic Carcinoma of the Trachea on Gallium-68 PSMA PET/CT Imaging.
    Clin Nucl Med. 2026 Apr 2. doi: 10.1097/RLU.0000000000006458.
    PubMed         Abstract available
    
    
32. MAKI H, Kagaya R, Hirota S, Mizutani Y, et al
    A Rare Case of Neurosarcoidosis With Symmetric Multilevel Dorsal Root Ganglia Uptake on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 Apr 3. doi: 10.1097/RLU.0000000000006472.
    PubMed         Abstract available
    
    
33. ZHENG K, Li Q, Liu Y, Wang Y, et al
    A Primitive Endobronchial Tumor Derived by Salivary Gland on FDG PET/CT.
    Clin Nucl Med. 2026 Apr 2. doi: 10.1097/RLU.0000000000006457.
    PubMed         Abstract available
    
    
34. WANG J, He S, Ran B, Dong A, et al
    Extracranial Metastases From FET-CREB Fusion-positive Intracranial Mesenchymal Tumor on FDG PET/CT.
    Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006459.
    PubMed         Abstract available
    
    
35. WANG W, Yan X, Yang S, Su X, et al
    Renal Diffuse Large B-cell Lymphoma Mimicking Acute Pyelonephritis on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006463.
    PubMed         Abstract available
    
    
36. TAHERI F, Tanha AS, Aboutorabi RB, Rostami M, et al
    Widespread Skeletal Metastases in Medullary Thyroid Carcinoma: Diagnostic Superiority of 68Ga-FAPI PET/CT Over Somatostatin Receptor-Targeted Imaging.
    Clin Nucl Med. 2026 Apr 2. doi: 10.1097/RLU.0000000000006450.
    PubMed         Abstract available
    
    
37. MARULANDA-CORZO V, Kakkar P, Sharbatdaran A, Sternberg CN, et al
    Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone Flare.
    Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006447.
    PubMed         Abstract available
    
    
38. ZHANG B, Li S, Lv C, Wang W, et al
    True Positive 18F-FDG PET/CT and Negative 123I-MIBG SPECT/CT in a Pediatric Patient With Bladder Malignant Paraganglioma.
    Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006377.
    PubMed         Abstract available
    
    
39. BALTACIOGLU MH, Sahin Oguz P
    Isolated Myocardial Metastases in a Neuroendocrine Tumor: 68Ga-DOTATATE PET/CT and Cardiac Magnetic Resonance Imaging Findings.
    Clin Nucl Med. 2026 Apr 2. doi: 10.1097/RLU.0000000000006464.
    PubMed         Abstract available
    
    
40. ZHENG M, Davis LM, States LJ, Zhuang H, et al
    Extensive Isolated Intracranial Recurrence of Primary Mediastinal B-Cell Lymphoma on FDG PET Imaging.
    Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006446.
    PubMed         Abstract available
    
    

    
    J Cereb Blood Flow Metab

41. KIM SJ, Ibrahimy A, Constantinescu CC, Hoye J, et al
    Receptor subtype distribution from PET occupancy studies: Novel analysis of maximum occupancy images using a selective drug and a non-selective tracer.
    J Cereb Blood Flow Metab. 2026 Apr 7:271678X261438226.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

42. CLERC OF, Romero Pabon AJ, Cuddy SAM, Bhimaniya S, et al
    Assessment of Cardiac Involvement in Rare Forms of Amyloidosis Using PET/CT with (124)I-Evuzamitide ((124)I-p5+14, AT-01).
    J Nucl Cardiol. 2026 Apr 2:102707. doi: 10.1016/j.nuclcard.2026.102707.
    PubMed         Abstract available
    
    

    
    J Nucl Med

43. KIESS AP, Sunderland JJ, Scott PJH, Hope TA, et al
    Response to the FDA Dosage Optimization Draft Guidance for Radiopharmaceutical Therapies.
    J Nucl Med. 2026 Apr 9:jnumed.126.272138. doi: 10.2967/jnumed.126.272138.
    PubMed        
    
    
44. LI R, Cao R, Zhang G, Ding L, et al
    Development of Dar3A Chelator and Construction of FAP-Targeted PET Probe as Proof of Concept and for First-in-Human Evaluation.
    J Nucl Med. 2026 Apr 9:jnumed.125.271421. doi: 10.2967/jnumed.125.271421.
    PubMed         Abstract available
    
    
45. AURIAC J, Lemoudda G, Hovhannisyan-Baghdasarian N, Pires M, et al
    Brain Metabolic Activity Measured by [(18)F]FDG PET/CT Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer.
    J Nucl Med. 2026 Apr 9:jnumed.125.271400. doi: 10.2967/jnumed.125.271400.
    PubMed         Abstract available
    
    
46. MORADPOUR M, Moradi Tochayi A, Houshmand S, Nwihim S, et al
    Patterns of Progression After Peptide Receptor Radiopharmaceutical Therapy.
    J Nucl Med. 2026 Apr 9:jnumed.125.270483. doi: 10.2967/jnumed.125.270483.
    PubMed         Abstract available
    
    
47. NAMBIAR DM, Esparza TJ, Lee W, Chung JY, et al
    A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver Cancer.
    J Nucl Med. 2026 Apr 9:jnumed.125.271565. doi: 10.2967/jnumed.125.271565.
    PubMed         Abstract available
    
    

    
    JAMA

48. EINSTEIN AJ, Williams MC, Weir-McCall JR, Shaw LJ, et al
    Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging.
    JAMA. 2026 Feb 25:e260703. doi: 10.1001/jama.2026.0703.
    PubMed         Abstract available
    
    

    
    Neurology

49. HUANG SC, Wang HC
    Reversible Dopaminergic Neuron Dysfunction in Methamphetamine-Associated Leukoencephalopathy: Insights From 99mTc-TRODAT-1 SPECT.
    Neurology. 2026;106:e214923.
    PubMed        
    
    
50. GOKCAL E, Becker JA, Horn MJ, Das AS, et al
    Extent of Tau and Its Cognitive Implications in Patients With Cerebral Amyloid Angiopathy Without Cognitive Impairment.
    Neurology. 2026;106:e214859.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

51. LIN K, Li M, Wang Y, Chen Z, et al
    Bibliometric analysis of programmed death ligand-1 positron emission tomography probe research: development, landscape, and technological evolution.
    Nucl Med Commun. 2026 Apr 3. doi: 10.1097/MNM.0000000000002152.
    PubMed         Abstract available
    
    
52. QIAN Z, Du B, Wan F, Zheng M, et al
    Quantitative [18F]-fluorodeoxyglucose PET analysis with a Gaussian normative template.
    Nucl Med Commun. 2026 Apr 6. doi: 10.1097/MNM.0000000000002155.
    PubMed         Abstract available
    
    
53. DURAK HM, Sanci A, Hepsen E, Yigman M, et al
    Prognostic value of preoperative gallium-68 prostate-specific membrane antigen PET/computed tomography in predicting biochemical recurrence after radical prostatectomy.
    Nucl Med Commun. 2026 Apr 3. doi: 10.1097/MNM.0000000000002149.
    PubMed         Abstract available
    
    
54. OKUYAN M, Sahin E, Elboga U, Yerdes E, et al
    Baseline fluorodeoxyglucose PET/computed tomography volumetric parameters predict response to transarterial radioembolization in primary and metastatic liver tumors.
    Nucl Med Commun. 2026 Mar 7. doi: 10.1097/MNM.0000000000002147.
    PubMed         Abstract available
    
    
55. JADHAV V, Verma P, Chandak A, Shinde P, et al
    Pilot feasibility study investigating 68Ga-NODAGA-RGD PET-computed tomography molecular angiogenesis imaging in patients with peripheral arterial diseases: can it be of potential clinical value?
    Nucl Med Commun. 2026 Apr 10. doi: 10.1097/MNM.0000000000002160.
    PubMed         Abstract available
    
    
56. SUBRAMANYAM P, Palaniswamy SS, Patel SH
    Added value of maximum standardized uptake value and diffusion-weighted imaging in staging of high risk breast cancer patients using simultaneous 18F-flurodeoxyglucose positron emission tomography and magnetic resonance imaging.
    Nucl Med Commun. 2026 Apr 10. doi: 10.1097/MNM.0000000000002156.
    PubMed         Abstract available
    
    
57. LIU D, Liu J
    The progress of fibroblast activation protein inhibitors PET/computed tomography in the diagnosis and treatment of lymphoma: a narrative review.
    Nucl Med Commun. 2026 Apr 10. doi: 10.1097/MNM.0000000000002162.
    PubMed         Abstract available
    
    
58. ZHENG Y, Tang G, Tian Y, Chen L, et al
    Comparative diagnostic performance of 18F-FAPI-42 versus 18F-FDG PET/computed tomography in detecting distant metastases of nasopharyngeal carcinoma and potential pitfalls.
    Nucl Med Commun. 2026 Apr 10. doi: 10.1097/MNM.0000000000002151.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

59. BALCERZYK M, Freire M, Fernandez De La Rosa R, Pozo MA, et al
    Precise dose verification in proton therapy via F-18 activation measured with positron emission tomography imaging.
    Phys Med Biol. 2026 Apr 9. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    

    
    PLoS One

60. GONZALES M, Kang X, Cort C, Adamson MM, et al
    White matter microstructure disruption associated with PET and cognitive impairment in Alzheimer's disease.
    PLoS One. 2026;21:e0346661.
    PubMed         Abstract available
    
    
61. 
    Retraction: Investigation of the effectiveness of CFRP strengthening of concrete made with recycled waste PET fine plastic aggregate.
    PLoS One. 2026;21:e0346319.
    PubMed        
    
    

    
    Semin Nucl Med

62. OZTEK MA, Shulkin BL, Parisi MT
    Pediatric infection imaging focusing on FDG PET/CT: Techniques, safety, and indications.
    Semin Nucl Med. 2026 Apr 8:S0001-2998(26)00082.
    PubMed         Abstract available
    
    
63. LIU B, Hendrikse E, van der Geest KSM, Brouwer E, et al
    PET imaging of polymyalgia rheumatica: update and future trends.
    Semin Nucl Med. 2026 Apr 7:S0001-2998(26)00077.
    PubMed         Abstract available
    
    
64. ALBANO D, Urso L, Treglia G, Bertagna F, et al
    The value of [(18)F]FDG PET/CT in fever of unknown origin (FUO): an update and future aspects.
    Semin Nucl Med. 2026 Apr 6:S0001-2998(26)00076.
    PubMed         Abstract available
    
    
65. DONNELLY R, Boyle N, McCarthy C, Murphy DJ, et al
    FDG PET in pulmonary sarcoidosis: An update and future aspects.
    Semin Nucl Med. 2026 Apr 4:S0001-2998(26)00075.
    PubMed         Abstract available
    
    
66. JAMAR F, van der Heijden WRP, van der Laken CJ, Beha N, et al
    PET/CT in inflammatory joint disorders: update and future trends.
    Semin Nucl Med. 2026 Apr 3:S0001-2998(26)00078.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum